Literature DB >> 596982

Behavioral despair in mice: a primary screening test for antidepressants.

R D Porsolt, A Bertin, M Jalfre.   

Abstract

A depressed state can be induced in mice by forcing them to swim in a narrow cylinder from which they cannot escape. After a brief period of vigorous activity the mice adopt a characteristic immobile posture which is readily identifiable. Immobility was reduced by tricyclic antidepressants, monoamine oxidase inhibitors and atypical antidepressants, as well as by electroconvulsive shock. Psychostimulants also reduced immobility but in contrast to antidepressants caused marked motor stimulation. Immobility was not affected by minor or major tranquilisers. These findings, closely parallel to those we have previously reported in rats, suggest that the procedure is selectively sensitive to antidepressant treatments. The mouse procedure is, however, more rapid and less costly than that with rats and is thus more suitable for the primary screening of antidepressant drugs.

Entities:  

Mesh:

Substances:

Year:  1977        PMID: 596982

Source DB:  PubMed          Journal:  Arch Int Pharmacodyn Ther        ISSN: 0003-9780


  806 in total

1.  Appropriate use of "knockout" mice as models of depression or models of testing the efficacy of antidepressants.

Authors:  A M Gardier; M Bourin
Journal:  Psychopharmacology (Berl)       Date:  2001-01       Impact factor: 4.530

Review 2.  Biochemical, behavioral, physiologic, and neurodevelopmental changes in mice deficient in monoamine oxidase A or B.

Authors:  D P Holschneider; K Chen; I Seif; J C Shih
Journal:  Brain Res Bull       Date:  2001-11-15       Impact factor: 4.077

3.  Loss of signaling through the G protein, Gz, results in abnormal platelet activation and altered responses to psychoactive drugs.

Authors:  J Yang; J Wu; M A Kowalska; A Dalvi; N Prevost; P J O'Brien; D Manning; M Poncz; I Lucki; J A Blendy; L F Brass
Journal:  Proc Natl Acad Sci U S A       Date:  2000-08-29       Impact factor: 11.205

4.  The CB1 receptor antagonist SR141716A selectively increases monoaminergic neurotransmission in the medial prefrontal cortex: implications for therapeutic actions.

Authors:  Eleni T Tzavara; Richard J Davis; Kenneth W Perry; Xia Li; Craig Salhoff; Frank P Bymaster; Jeffrey M Witkin; George G Nomikos
Journal:  Br J Pharmacol       Date:  2003-02       Impact factor: 8.739

5.  Maternal separation with early weaning: a novel mouse model of early life neglect.

Authors:  Elizabeth D George; Kelly A Bordner; Hani M Elwafi; Arthur A Simen
Journal:  BMC Neurosci       Date:  2010-09-29       Impact factor: 3.288

6.  Human N-methyl D-aspartate receptor antibodies alter memory and behaviour in mice.

Authors:  Jesús Planagumà; Frank Leypoldt; Francesco Mannara; Javier Gutiérrez-Cuesta; Elena Martín-García; Esther Aguilar; Maarten J Titulaer; Mar Petit-Pedrol; Ankit Jain; Rita Balice-Gordon; Melike Lakadamyali; Francesc Graus; Rafael Maldonado; Josep Dalmau
Journal:  Brain       Date:  2014-11-11       Impact factor: 13.501

7.  Effect of PDE10A inhibitors on MK-801-induced immobility in the forced swim test.

Authors:  Barbara Langen; Rita Dost; Ute Egerland; Hans Stange; Norbert Hoefgen
Journal:  Psychopharmacology (Berl)       Date:  2011-11-16       Impact factor: 4.530

8.  Hippocampal α7 nicotinic ACh receptors contribute to modulation of depression-like behaviour in C57BL/6J mice.

Authors:  Yann S Mineur; Tenna N Mose; Sam Blakeman; Marina R Picciotto
Journal:  Br J Pharmacol       Date:  2017-04-08       Impact factor: 8.739

9.  An extract of Synedrella nodiflora (L) Gaertn exhibits antidepressant properties through monoaminergic mechanisms.

Authors:  Patrick Amoateng; Kennedy Kwami Edem Kukuia; Jeffrey Amoako Mensah; Dorcas Osei-Safo; Samuel Adjei; Audrey Akyea Eklemet; Emmanuel Atsu Vinyo; Thomas K Karikari
Journal:  Metab Brain Dis       Date:  2018-05-12       Impact factor: 3.584

Review 10.  Molecular brake pad hypothesis: pulling off the brakes for emotional memory.

Authors:  Annie Vogel-Ciernia; Marcelo A Wood
Journal:  Rev Neurosci       Date:  2012       Impact factor: 4.353

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.